Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Cash from Operations (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Cash from Operations for 3 consecutive years, with 29727000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 35.8% to 29727000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 173427000.0, a 32.98% decrease, with the full-year FY2025 number at 173427000.0, down 32.98% from a year prior.
  • Cash from Operations was 29727000.0 for Q4 2025 at Nuvation Bio, up from 52900000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 15029000.0 in Q4 2023 to a low of 52900000.0 in Q3 2025.
  • A 3-year average of 30986583.33 and a median of 30406000.0 in 2024 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: plummeted 208.08% in 2024, then surged 35.8% in 2025.
  • Nuvation Bio's Cash from Operations stood at 15029000.0 in 2023, then tumbled by 208.08% to 46302000.0 in 2024, then soared by 35.8% to 29727000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Cash from Operations are 29727000.0 (Q4 2025), 52900000.0 (Q3 2025), and 48200000.0 (Q2 2025).